Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CRMXX vs. MDIZX: which is better?

Bottom line

CRMXX vs MDIZX: the short answer

CRMXX (MFS U.S. Government Cash Reserve Fund) and MDIZX (MFS International Diversification Fund) are both money market funds.

CRMXX is cheaper at 0.45% vs 0.72% — a difference of $27 a year per $10,000 invested.

Over five years, MDIZX returned +6.9% a year vs +2.1% for CRMXX (reporting dates differ).

Updated Nov 19, 2026

CRMXX vs MDIZX side by side

CRMXXMDIZX
TypeMoney market fundMutual fund
Fund familyMFSMFS
CategoryMoney MarketInternational Stock
Expense ratio0.45%0.72%
Annual cost per $10k$45$72
10-yr cost on $10k (prospectus)$1,260$906
Max front load0%0%
12b-1 fee0.5%0%
1-yr return+4.9%+28.0%
5-yr return (annualized)+2.1%+6.9%
10-yr return (annualized)+1.4%+9.2%
Best quarter——
Worst quarter——
Net assets (fund)—$44.6B
Number of holdings—7
Portfolio turnover—1%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CRMXX and MDIZX share none of their top holdings.

CRMXX top 10

    MDIZX top 10

    1. MFS Research International Fund — 27.36%
    2. MFS Emerging Markets Equity Fund — 17.55%
    3. MFS International Growth Fund — 15.00%
    4. MFS International Intrinsic Equity Fund — 14.97%
    5. MFS International Large Cap Value Fund — 14.93%
    6. MFS International New Discovery Fund — 9.97%
    7. MFS Institutional Money Market Portfolio — 0.17%

    FAQ

    What is the difference between CRMXX and MDIZX?
    CRMXX (MFS U.S. Government Cash Reserve Fund) and MDIZX (MFS International Diversification Fund) are both money market funds. CRMXX is cheaper at 0.45% vs 0.72% — a difference of $27 a year per $10,000 invested.
    Which is cheaper, CRMXX or MDIZX?
    CRMXX has the lower expense ratio (0.45%).
    Should I own both CRMXX and MDIZX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.